1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of DAG1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions EXP 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of DAG1 mRNA] CTD PMID:22206623 17beta-estradiol multiple interactions ISO RGD:1344302 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of DAG1 mRNA CTD PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1344302 6480464 Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of DAG1 mRNA] CTD PMID:11007951 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of DAG1 mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:621890 6480464 Tetrachlorodibenzodioxin affects the expression of DAG1 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with AHR gene mutant form] results in decreased expression of DAG1 mRNA, [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of DAG1 mRNA CTD PMID:19465110 , PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1344302 6480464 Tetrachlorodibenzodioxin results in decreased expression of DAG1 mRNA CTD PMID:11007951 2-methylcholine affects expression ISO RGD:1344302 6480464 beta-methylcholine affects the expression of DAG1 mRNA CTD PMID:21179406 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of DAG1 mRNA CTD PMID:26251327 acrolein multiple interactions ISO RGD:1344302 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of DAG1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of DAG1 mRNA CTD PMID:32699268 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of DAG1 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:1344302 6480464 Aflatoxin B1 results in decreased methylation of DAG1 exon CTD PMID:30157460 aflatoxin B2 increases methylation ISO RGD:1344302 6480464 aflatoxin B2 results in increased methylation of DAG1 promoter CTD PMID:30157460 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of DAG1 mRNA CTD PMID:16236135 all-trans-retinoic acid decreases expression ISO RGD:1344302 6480464 Tretinoin results in decreased expression of DAG1 mRNA CTD PMID:15894607 , PMID:17045167 all-trans-retinoic acid multiple interactions ISO RGD:1344302 6480464 [Tretinoin co-treated with arsenic trioxide] results in decreased expression of DAG1 mRNA CTD PMID:15894607 alpha-pinene multiple interactions ISO RGD:1344302 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of DAG1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of DAG1 mRNA CTD PMID:32699268 ammonium chloride affects expression ISO RGD:621890 6480464 Ammonium Chloride affects the expression of DAG1 mRNA CTD PMID:16483693 amphetamine decreases expression ISO RGD:621890 6480464 Amphetamine results in decreased expression of DAG1 mRNA CTD PMID:30779732 arsenous acid multiple interactions ISO RGD:1344302 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of DAG1 mRNA CTD PMID:15894607 benzo[a]pyrene decreases expression EXP 6480464 Benzoapyrene results in decreased expression of DAG1 mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO RGD:1344302 6480464 Benzoapyrene affects the methylation of DAG1 exon, Benzoapyrene affects the methylation of DAG1 promoter CTD PMID:30157460 benzo[a]pyrene decreases methylation ISO RGD:1344302 6480464 Benzoapyrene results in decreased methylation of DAG1 5' UTR CTD PMID:27901495 benzo[a]pyrene multiple interactions EXP 6480464 AHR protein affects the reaction [Benzoapyrene affects the expression of DAG1 mRNA] CTD PMID:22228805 benzo[a]pyrene increases expression EXP 6480464 Benzoapyrene results in increased expression of DAG1 mRNA CTD PMID:22228805 benzo[e]pyrene increases methylation ISO RGD:1344302 6480464 benzoepyrene results in increased methylation of DAG1 promoter CTD PMID:30157460 benzo[e]pyrene decreases methylation ISO RGD:1344302 6480464 benzoepyrene results in decreased methylation of DAG1 exon CTD PMID:30157460 bisphenol A affects expression ISO RGD:621890 6480464 bisphenol A affects the expression of DAG1 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:621890 6480464 bisphenol A results in decreased expression of DAG1 mRNA CTD PMID:27697584 cadmium atom increases expression ISO RGD:1344302 6480464 Cadmium results in increased expression of DAG1 mRNA CTD PMID:24376830 carbamazepine affects expression ISO RGD:1344302 6480464 Carbamazepine affects the expression of DAG1 mRNA CTD PMID:25979313 carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 chloroprene increases expression ISO RGD:621890 6480464 Chloroprene results in increased expression of DAG1 mRNA CTD PMID:23125180 cobalt dichloride decreases expression ISO RGD:1344302 6480464 cobaltous chloride results in decreased expression of DAG1 mRNA CTD PMID:19376846 copper atom multiple interactions EXP 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of DAG1 mRNA CTD PMID:15467011 copper atom multiple interactions ISO RGD:1344302 6480464 [Disulfiram binds to Copper] which results in increased expression of DAG1 mRNA CTD PMID:24690739 copper(0) multiple interactions EXP 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of DAG1 mRNA CTD PMID:15467011 copper(0) multiple interactions ISO RGD:1344302 6480464 [Disulfiram binds to Copper] which results in increased expression of DAG1 mRNA CTD PMID:24690739 cycloheximide multiple interactions ISO RGD:1344302 6480464 Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of DAG1 mRNA] CTD PMID:11007951 cyclosporin A decreases expression ISO RGD:1344302 6480464 Cyclosporine results in decreased expression of DAG1 mRNA CTD PMID:20106945 , PMID:25562108 diarsenic trioxide multiple interactions ISO RGD:1344302 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of DAG1 mRNA CTD PMID:15894607 dicrotophos increases expression ISO RGD:1344302 6480464 dicrotophos results in increased expression of DAG1 mRNA CTD PMID:28302478 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DAG1 mRNA CTD PMID:30529165 disulfiram multiple interactions ISO RGD:1344302 6480464 [Disulfiram binds to Copper] which results in increased expression of DAG1 mRNA CTD PMID:24690739 dorsomorphin multiple interactions ISO RGD:1344302 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 doxorubicin affects response to substance ISO RGD:1344302 6480464 DAG1 protein affects the susceptibility to Doxorubicin CTD PMID:16217747 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of DAG1 mRNA CTD PMID:19277126 endosulfan affects expression ISO RGD:621890 6480464 Endosulfan affects the expression of DAG1 mRNA CTD PMID:29391264 ethanol multiple interactions ISO RGD:1344302 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of DAG1 mRNA CTD PMID:29432896 ethanol affects splicing EXP 6480464 Ethanol affects the splicing of DAG1 mRNA CTD PMID:30319688 ethanol increases expression EXP 6480464 Ethanol results in increased expression of DAG1 mRNA CTD PMID:30319688 fenvalerate increases expression ISO RGD:621890 6480464 fenvalerate results in increased expression of DAG1 mRNA CTD PMID:30307764 finasteride increases expression ISO RGD:621890 6480464 Finasteride results in increased expression of DAG1 mRNA CTD PMID:24136188 flutamide decreases expression ISO RGD:621890 6480464 Flutamide results in decreased expression of DAG1 mRNA CTD PMID:24793618 folic acid multiple interactions EXP 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of DAG1 mRNA] CTD PMID:22206623 isoprenaline decreases expression ISO RGD:621890 6480464 Isoproterenol results in decreased expression of DAG1 CTD PMID:18808529 LY294002 multiple interactions ISO RGD:1344302 6480464 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of DAG1 mRNA] CTD PMID:12710931 methapyrilene decreases methylation ISO RGD:1344302 6480464 Methapyrilene results in decreased methylation of DAG1 exon CTD PMID:30157460 methapyrilene increases methylation ISO RGD:1344302 6480464 Methapyrilene results in increased methylation of DAG1 promoter CTD PMID:30157460 methapyrilene decreases expression ISO RGD:621890 6480464 Methapyrilene results in decreased expression of DAG1 mRNA CTD PMID:30467583 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:1344302 6480464 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of DAG1 mRNA] CTD PMID:12710931 nefazodone decreases expression ISO RGD:621890 6480464 nefazodone results in decreased expression of DAG1 mRNA CTD PMID:24136188 nimesulide decreases expression ISO RGD:621890 6480464 nimesulide results in decreased expression of DAG1 mRNA CTD PMID:24136188 oxaliplatin increases expression ISO RGD:1344302 6480464 oxaliplatin results in increased expression of DAG1 mRNA CTD PMID:17762391 ozone decreases expression ISO RGD:621890 6480464 Ozone results in decreased expression of DAG1 mRNA CTD PMID:16716893 ozone multiple interactions ISO RGD:1344302 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of DAG1 mRNA more ... CTD PMID:32699268 paracetamol increases expression ISO RGD:1344302 6480464 Acetaminophen results in increased expression of DAG1 mRNA CTD PMID:22230336 PCB138 increases expression ISO RGD:621890 6480464 2 more ... CTD PMID:23829299 perfluorooctanoic acid decreases expression ISO RGD:1344302 6480464 perfluorooctanoic acid results in decreased expression of DAG1 protein CTD PMID:26879310 PhIP increases expression ISO RGD:621890 6480464 2-amino-1-methyl-6-phenylimidazo4, 5-bpyridine results in increased expression of DAG1 mRNA CTD PMID:15215175 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of DAG1 mRNA CTD PMID:18301758 pirinixic acid increases expression ISO RGD:621890 6480464 pirinixic acid results in increased expression of DAG1 mRNA CTD PMID:22484513 potassium dichromate increases expression ISO RGD:1344302 6480464 Potassium Dichromate results in increased expression of DAG1 protein CTD PMID:23718831 raloxifene increases expression ISO RGD:1344302 6480464 Raloxifene Hydrochloride results in increased expression of DAG1 mRNA CTD PMID:16497877 reactive oxygen species multiple interactions ISO RGD:621890 6480464 Reactive Oxygen Species inhibits the reaction [DAG1 protein modified form binds to AGRN protein] CTD PMID:16672922 reactive oxygen species decreases glycosylation ISO RGD:621890 6480464 Reactive Oxygen Species results in decreased glycosylation of DAG1 protein CTD PMID:16672922 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of DAG1 mRNA CTD PMID:22610192 resveratrol decreases expression ISO RGD:1344302 6480464 resveratrol results in decreased expression of DAG1 protein CTD PMID:18089832 sarin decreases expression ISO RGD:1344302 6480464 Sarin results in decreased expression of DAG1 mRNA CTD PMID:19522546 SB 431542 multiple interactions ISO RGD:1344302 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1344302 6480464 Silicon Dioxide results in decreased expression of DAG1 mRNA CTD PMID:25351596 silver atom decreases expression ISO RGD:1344302 6480464 Silver results in decreased expression of DAG1 mRNA CTD PMID:26551752 silver atom decreases expression EXP 6480464 Silver results in decreased expression of DAG1 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1344302 6480464 Silver results in decreased expression of DAG1 mRNA CTD PMID:26551752 silver(0) decreases expression EXP 6480464 Silver results in decreased expression of DAG1 mRNA CTD PMID:27131904 Soman increases expression ISO RGD:621890 6480464 Soman results in increased expression of DAG1 mRNA CTD PMID:19281266 Soman decreases expression ISO RGD:621890 6480464 Soman results in decreased expression of DAG1 mRNA CTD PMID:19281266 tamoxifen increases expression ISO RGD:1344302 6480464 Tamoxifen results in increased expression of DAG1 mRNA CTD PMID:15604281 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of DAG1 mRNA CTD PMID:17484886 trichostatin A increases expression ISO RGD:1344302 6480464 trichostatin A results in increased expression of DAG1 mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO RGD:1344302 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of DAG1 mRNA CTD PMID:27188386 tungsten decreases expression EXP 6480464 Tungsten results in decreased expression of DAG1 mRNA CTD PMID:30912803 valproic acid decreases expression ISO RGD:1344302 6480464 Valproic Acid results in decreased expression of DAG1 mRNA CTD PMID:29154799 valproic acid multiple interactions ISO RGD:1344302 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of DAG1 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1344302 6480464 Valproic Acid results in increased expression of DAG1 mRNA CTD PMID:23179753 , PMID:26272509 valproic acid affects expression ISO RGD:1344302 6480464 Valproic Acid affects the expression of DAG1 mRNA CTD PMID:25979313 vinclozolin decreases expression ISO RGD:621890 6480464 vinclozolin results in decreased expression of DAG1 mRNA CTD PMID:18042343 vinclozolin affects expression ISO RGD:621890 6480464 vinclozolin affects the expression of DAG1 mRNA CTD PMID:19015723